Navigation Links
Preventing or reducing enlarged heart may decrease risk for diabetes
Date:10/31/2007

o already have diabetes, high blood pressure treatment is less effective at reducing their LVH compared to patients without diabetes. In addition, regression of LVH in hypertensive patients with diabetes does not appear to be associated with a reduction in cardiovascular events, according to a 2006 study by Dr. Okin and colleagues, making prevention of diabetes in patients with hypertension an important goal.


'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Preventing mental decline in the aged
2. Preventing white coat hypertension
3. Green tea beneficial in preventing osteoarthritis
4. Preventing Childhood Deaths
5. Preventing Vision Loss
6. Preventing Vision Loss
7. Preventing Colorectal Cancer
8. Preventing Prostate Cancer
9. Lycopene Can Help In Preventing Prostate Cancer
10. Heart Drug Also Effective In Preventing Specific Causes Of Death
11. Preventing cavities in children

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...zlesmile,llc www.dazzlesmile.com andOptimalHealthS...67-pagefederallawsuitagainstEpicAdvertisingAKAAzoo...esLimited,andAtLastFulfillment.The13-countComplain...ictofUtah,allegesmassivenationalconsumerfraud,coun...oducts,violationsoftheRacketeeringInfluencedandCor...
(Date:11/25/2009)...roveOverallOutcomesforLungCancer ,, WASHINGTO...rAlliance-California(LCA-CA)issuedits2ndAnnual Rep...ntofprogressbeingmadeagainstthislethaldiseaseinthe...ance(LCA),theonlynationalorganizationdedicatedexcl...ithoratriskforlungcancer. ,, (Photo: http://www...
(Date:11/25/2009)...matology (ASH) is pleased to recognize the followi...bstracts in the categories of undergraduate studen...ysician, and post-doctoral,fellow. Merit Award wi...g,travel reimbursement. , The 2009 Merit Award ...imberly Fan , Donor Dendritic Cells Home to Lymph...
(Date:11/25/2009)... , An innovative treatment for HIV patients dev...ers has passed its first clinical trial with flyin...stomized for each individual patient, and was deve...e of the MUHC in collaboration with Dr. R. Skaly f...ade for the individual patient an "haute couture"...
(Date:11/25/2009)...atients with liver lesions, researchers find , ...ding the drug cetuximab to neoadjuvant chemotherap...ul surgery in colorectal cancer patients with inop...ests. , , Tumors spread to other parts of the ... cancer. Most commonly, the cancer spreads to the ...
Breaking Medicine News(10 mins):Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2Health News:ASH announces 2009 Merit Award winners 2Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Cetuximab Helps Treat Colorectal Cancer 2
... due to its First To File ... Pharmaceuticals Inc.,(RPI), a wholly owned subsid...ed today that RLL has received tentative approval ...Valsartan Tablets,were $1.3 billion (IMS - MAT: Ju...
...onal, Inc. (OTC. Bulletin Board: TCAR.OB) today an...er 24, 2007, with The Hain Celestial,Group, Inc. (...d and personal,care products company. Under the te...1, 2006, there were 7,454,582 shares of,TenderCare...
...ated, doing business as "Merge Healthcare" (Nasdaq...ical imaging software and services provider,announ...ced restatement of,its financial statements, the C... 2005, and 2006, as well as other,restated financi...
...RUSSIA, Pa., Oct. 29 Universal,Health Services, I...d net,income was $28.9 million, or $.54 per dilute...red to $113.9 million, or $2.00 per diluted share,...hare, as compared to $225.3 million, or $3.89 per ...
... that,global prices for most of its soy protein in...ding on the product line. The increase takes effec... Chairman Craig Binetti said, "Market conditions a...provide innovative, economical solutions." For se...
...; RO.S),a world-leading healthcare provider of pha...it has extended its offer to acquire all of the,ou..., Inc. (Nasdaq: VMSI ),to 5:00 p.m., New York Cit...her terms and conditions of the tender offer,remai...
Other Medicine News:Health News:Ranbaxy Receives Tentative Approval For Valsartan Tablets 2Health News:TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock 2Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 2Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 3Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 4Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 5Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 2Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 3Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 4Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 5Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 6Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 7Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 8Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 9Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 10Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 11Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 12Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 13Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 14Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 15Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 16Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 17Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 18Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 19Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 20Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 21Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 22Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 23Health News:Universal Health Services, Inc. Reports 2007 Third Quarter Earnings 24Health News:Solae Announces Global Price Increase for Soy Protein Ingredients 2Health News:Roche Extends Tender Offer for Ventana 2Health News:Roche Extends Tender Offer for Ventana 3Health News:Roche Extends Tender Offer for Ventana 4
(Date:11/24/2009)...ccumetrics,Inc.,aprivately-helddeveloperandmarkete...o-usediagnosticsystemformeasuringanindividual,sres...andaspirin),announcedtodaythatTimothyI.Still,Presi...FinancialOfficerofAccumetrics,willbepresentingacor...eConferencebeingheldinNewYorkCityonDecember1-2,200...
(Date:11/24/2009).../--SpartaSystems,Inc.,themakerofTrackWisesoftwarea...olutions,todayannouncedthatSSLInternationalplc,ara...mpanyforgloballyrecognizedbrandssuchasDurexandScho...mentSystem(EQMS).ThecompanyisnowleveragingtheTrack...sthatincludeCorrectiveandPreventiveAction(CAPA)man...
(Date:11/24/2009)...SNewswire/--America,spharmaceuticalresearchandbiot...totreatorpreventHIV/AIDSandrelatedconditions,accor...searchandManufacturersofAmerica(PhRMA).December1ma...nesscampaignthatoriginatedatthe1988WorldSummitofMi..., "Wearegreatlyencouragedbythesecriticallyimportan...
Breaking Medicine Technology:Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 3New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Cardiac Science Appoints Healthcare Executive Ronald A Andrews Jr to Board of Directors 6032 1Cardiac Science Appoints Healthcare Executive Ronald A Andrews Jr to Board of Directors 6032 2Cardiac Science Appoints Healthcare Executive Ronald A Andrews Jr to Board of Directors 6032 3Cardiac Science Appoints Healthcare Executive Ronald A Andrews Jr to Board of Directors 6032 4Cardiac Science Appoints Healthcare Executive Ronald A Andrews Jr to Board of Directors 6032 5Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6029 1Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6029 2Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6029 3Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6029 4Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6029 5Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6029 6Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6029 7Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6029 8Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6029 9Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6029 10Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6029 11Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 1Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 2Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 3Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 4Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 5Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 6Trubion Pharmaceuticals Inc Reports Third Quarter and Nine Months 2009 Financial Results 6026 7
...CE V Drug Eluting Stent Demonstrates Clinically Me...y Endpoints, Including an 88 Percent Reduction in ...NDO, Fla., March 29 Long-term data presented toda... trial demonstrated that the clinical advantages o...t System continued to increase between two and thr...
..., March 28 Boston Scientific Corporation (NYSE: ... economic and quality of life outcomes, based on o...results found that while the overall cost effectiv...versus coronary artery bypass graft (CABG) surgery...was more cost effective than CABG in patients with...
Other Medicine Technology:Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 2Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 3Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 4Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 5SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 2SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 3SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 4SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 5
Fisherbrand Plastic Microhematocrit Tubes
SafeCrit® Microhematocrit Tubes
Innova 4100
RX imola™
Medicine Products: